Articles

We now have drugs that can replace the GLP-1 hormone and we have drugs that can reduce the destruction of GLP-1. Now we may have a drug that increases the production of GLP-1.

Juice extracted from North American lowbush blueberries, biotransformed with bacteria from the skin of the fruit, holds great promise as an anti-obesity and anti-diabetic agent, showing a reduction in blood glucose by 35%. 

The study of the role of an enzyme called 12-Lipoxygenase (12-LO), may find the answer to preventing  the destruction of the beta-cells and could be a vital step in preventing Type 1 diabetes.

Insulin can be safely and effectively used as a first-line treatment, in combination with metformin, in patients with newly diagnosed Type 2 diabetes, with high rates of patient satisfaction and compliance, results of a study indicate. 

Researchers find a gene that protects mice on a high-fat diet from becoming obese. University of Michigan researchers have identified a gene that acts as a master switch to control obesity. When the switch is turned off, even high-fat-diet mice remain thin.

Ninety-three percent of participants exceeded the recommended percentage of daily calories from fat, 85 percent exceeded the saturated fat recommendation and 92 percent consumed too much sodium in their regular diets.

A new study may give new meaning to the adage, “You are what you eat.”  The DNA isolated from the muscles of people with diabetes bears chemical marks not found in those who respond normally to rising blood sugar levels, according to the report. The discovery shows that we are …

Using skin cells from people with Type 1 diabetes, researchers were able to produce cells that made insulin in response to changing blood sugar levels.

Researchers say they know why obesity leads to diabetes and cardiovascular disease, a finding that may help experts target therapies to limit the health impact of being very overweight.  

Increased time spent sedentary is prospectively associated with elevated fasting insulin levels in healthy middle-aged adults independent of the amount of time spent in moderate and vigorous-intensity physical activity (MVPA), according to the results of a population-based study.